17 Salmonella and the Breast: A Literature Review of Salmonella-Induced Breast Abscesses

Publication
Article
Miami Breast Cancer Conference® Abstracts Supplement42nd Annual Miami Breast Cancer Conference® - Abstracts
Volume 39
Issue 4
Pages: 10

17 Salmonella and the Breast: A Literature Review of Salmonella-Induced Breast Abscesses

17 Salmonella and the Breast: A Literature Review of Salmonella-Induced Breast Abscesses

Background

Breast abscesses caused by salmonella are especially rare, accounting for less than 1% of cases. This study was prompted by the challenging management of a nonpregnant, nonlactating 22-year-old immunocompromised women with multiple bilateral breast abscesses following a unique prodrome of diarrheal illness. The goal was to identify patterns, risk factors, and effective management strategies through a systematic review of the literature.

Materials and Methods

A literature review of all the documented cases (1907-2024) of salmonella breast abscesses was conducted using PubMed to analyze demographics, clinical presentation, pathogen subtypes, geographic distribution, and treatment outcomes. Statistical analysis was performed using χ2 tests to identify significant associations.

Results

Demographic analysis of 41 cases revealed that women accounted for most cases (90%), with the median patient age being 32 years. The geographic distribution revealed that most cases were reported in India (37%). Statistical analysis showed a significant association between country of origin and salmonella subtype, with more typhoidal species presenting in developing countries (P = .00005). Travel history was documented in 15% of cases, with 83% of patients who traveled to high-risk countries presenting with a prodrome of diarrhea, highlighting exposure as a potential risk factor. Most abscesses were unilateral (90%). Immunocompromised patients were more likely to develop bilateral abscesses (P = .03). Most patients presented with single abscesses (85%). Most patients (61%) presented with prodromal symptoms of diarrhea and fever. Successful treatment universally involved surgical drainage combined with targeted antibiotics.

Conclusion

This literature review emphasizes the rarity of salmonella breast abscesses. The unique prodrome of diarrheal illness and fever in 61% of cases supports the suspected pathophysiology of hematogenous seeding from a systemic infection or lymphatic spread following gastrointestinal colonization. Considering factors such as country of origin, recent travel, gastrointestinal symptoms, lactation status, and immunosuppression is crucial when developing a differential diagnosis and initiating antibiotics. Awareness of rare pathogens not only highlights the importance of obtaining cultures to ensure accurate and effective treatment but also helps to prevent recurrence, mitigate unnecessary antibiotic use, and combat the growing threat of antimicrobial resistance. Ultimately, the findings of this review serve as a call to action for interdisciplinary collaboration across infectious disease, radiology, surgery, oncology, and pathology. By fostering earlier recognition and evidence-based interventions, we can achieve improved outcomes for patients facing this rare condition.

Articles in this issue

3 Intraoperative Radiotherapy: Alive and Well in the Bronx
3 Intraoperative Radiotherapy: Alive and Well in the Bronx
4 Evaluating AI-Driven Responses in Breast Reconstruction: A Comparative Study of Response Formats
4 Evaluating AI-Driven Responses in Breast Reconstruction: A Comparative Study of Response Formats
5 Correlation Between Visual Impairment and Breast Cancer: A Cross-Sectional Study Based on the National Health Interview Surveys
5 Correlation Between Visual Impairment and Breast Cancer: A Cross-Sectional Study Based on the National Health Interview Surveys
6 Peer Support Programming Among Women At-Risk for Surviving Breast Cancer: Facilitators and Barriers to Community-Based Patient Navigation and the Role of Quality of Life
6 Peer Support Programming Among Women At-Risk for Surviving Breast Cancer: Facilitators and Barriers to Community-Based Patient Navigation and the Role of Quality of Life
7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features
7 Metaplastic Breast Cancer: A Retrospective Chart Review of Clinical Features
8 A Case Series Exploring Characteristics and Outcomes of Metachronous Primary Breast and Lung Cancer in a Diverse Cohort
8 A Case Series Exploring Characteristics and Outcomes of Metachronous Primary Breast and Lung Cancer in a Diverse Cohort
9 Body Mass Index, Cancer Risk Behaviors, and Readiness for Dietary Change Among Women Surviving With Breast Cancer
9 Body Mass Index, Cancer Risk Behaviors, and Readiness for Dietary Change Among Women Surviving With Breast Cancer
10 AI as a Bridge: Can ChatGPT Help Patients Understand Their Breast Radiology Reports?
10 AI as a Bridge: Can ChatGPT Help Patients Understand Their Breast Radiology Reports?
12 Gut Microbiome Composition and Pathological Complete Response After Chemotherapy in Breast Cancer: Insights From a Pilot Study
12 Gut Microbiome Composition and Pathological Complete Response After Chemotherapy in Breast Cancer: Insights From a Pilot Study
13 Preliminary Analysis of Change During Treatment of Financial Toxicity and Quality of Life in Breast Cancer Patients
13 Preliminary Analysis of Change During Treatment of Financial Toxicity and Quality of Life in Breast Cancer Patients
15 Utilizing Circulating Tumor Cells to Guide HER2-Directed Therapy in IHC/FISH-Negative HER2+ Metastatic Breast Cancer
15 Utilizing Circulating Tumor Cells to Guide HER2-Directed Therapy in IHC/FISH-Negative HER2+ Metastatic Breast Cancer
16 A Miami Hospital’s Infrastructure to Help Decrease Late-Stage Breast Cancer Diagnosis and Improve Health Equity
16 A Miami Hospital’s Infrastructure to Help Decrease Late-Stage Breast Cancer Diagnosis and Improve Health Equity
17 Salmonella and the Breast: A Literature Review of Salmonella-Induced Breast Abscesses
17 Salmonella and the Breast: A Literature Review of Salmonella-Induced Breast Abscesses
18 Tolerability of First-Line Treatment With Ribociclib for Metastatic Breast Cancer Using 2 Large US Data Sources
18 Tolerability of First-Line Treatment With Ribociclib for Metastatic Breast Cancer Using 2 Large US Data Sources
20 Impact of Ribociclib Dose Reduction on Efficacy in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast
20 Impact of Ribociclib Dose Reduction on Efficacy in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast
Recent Videos
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.
Breast oncologist Jade E. Jones, MD, says she tries to send patients with BRCA-mutant HR-positive TNBC to clinical trials that use PARP inhibitors.
Following progression on a CDK4/6 inhibitor, ascertaining the endocrine sensitivity of HR-positive/HER2-negative disease may inform sequential treatment.
T-DXd improved progression-free survival over standard chemotherapy among patients with HR-positive/triple-negative breast cancer in DESTINY-Breast04.
The use of chemotherapy trended towards improved recurrence-free intervals in older patients with high-risk tumors as determined via the MammaPrint assay.
Use of a pharmacist-directed resource appears to improve provider confidence and adverse effect monitoring for patients undergoing infusion therapy.
Reshma L. Mahtani, DO, describes how updates from the DESTINY-Breast09, ASCENT-04, and VERITAC-2 trials may shift practices in the breast cancer field.